|Application ||WB, IHC-P|
|Dilution||IHC-P (7.5 µg/ml), WB (1:500-1:3000),|
|Other Names||Junctional adhesion molecule B, JAM-B, Junctional adhesion molecule 2, JAM-2, Vascular endothelial junction-associated molecule, VE-JAM, CD322, JAM2, C21orf43, VEJAM|
|Target/Specificity||Human JAM-B / JAM2|
|Reconstitution & Storage||Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.|
|Precautions||JAM2 Antibody (aa1-294) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||May play a role in the processes of lymphocyte homing to secondary lymphoid organs.|
|Cellular Location||Cell junction, tight junction. Cell membrane; Single-pass type I membrane protein. Note=Localized at tight junctions of both epithelial and endothelial cells.|
|Tissue Location||Highest expression in the heart, placenta, lung, foreskin and lymph node. Prominently expressed on high endothelial venules, also present on the endothelia of other vessels. Localized to the intercellular boundaries of high endothelial cells.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
May play a role in the processes of lymphocyte homing to secondary lymphoid organs.
Palmeri D.,et al.J. Biol. Chem. 275:19139-19145(2000).
Cunningham S.A.,et al.J. Biol. Chem. 275:34750-34756(2000).
Gardiner K.,et al.Genomics 79:833-843(2002).
Clark H.F.,et al.Genome Res. 13:2265-2270(2003).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
If you have any additional inquiries please email technical services at email@example.com.